comparemela.com

Latest Breaking News On - Prnewswire capsida biotherapeutics inc - Page 1 : comparemela.com

Capsida Biotherapeutics Enters Strategic Collaboration With Kate Therapeutics to Manufacture KateTx s Next-Generation Gene Therapies

/PRNewswire/ Capsida Biotherapeutics Inc. ("Capsida") and Kate Therapeutics ("KateTx") today announced a strategic partnership to leverage Capsida s.

Beth seidenbergCapsida biotherapeuticsPeter anastasiouViviana gradinaruKevin forrestPrnewswire capsida biotherapeutics incKate therapeuticsWestlake village biopartnersVersant venturesCapsida biotherapeutics kate therapeutics

Capsida Biotherapeutics Appoints Susan Catalano, Ph D as Chief Scientific Officer

/PRNewswire/ Capsida Biotherapeutics Inc. ("Capsida") today announced the appointment of Susan Catalano, Ph.D., as the company s Chief Scientific Officer.

United statesSusan catalanoPeter anastasiouNick goedenNicholas flytzanisUniversity of californiaNational institutes of healthUniversity of pittsburgh school medicineAcumen pharmaceuticalsPrnewswire capsida biotherapeutics incTechnology officerPittsburgh venture capital association outstanding entrepreneurCarnegie science center entrepreneurRigel pharmaceuticalsBarnard collegeChief research

Capsida Biotherapeutics Announces Appointment of Julie Hakim as Chief Financial Officer

/PRNewswire/ Capsida Biotherapeutics Inc. ("Capsida") today announced the appointment of Julie Hakim to the role of chief financial officer (CFO). Ms. Hakim.

United statesNew jerseyPeter anastasiouJulie hakimNovation pharmaceuticalsCentral college in napervillePrnewswire capsida biotherapeutics incSequoia vaccinesNorth americaNorth americanNorth central collegeCapsida biotherapeutics

Capsida Biotherapeutics Announces Strategic Collaboration with Prevail, a Wholly Owned Subsidiary of Lilly, to Develop Non-Invasive Gene Therapies for CNS Diseases

/PRNewswire/ Capsida Biotherapeutics Inc. ("Capsida") today announced a multi-year strategic collaboration with Prevail Therapeutics ("Prevail"), a wholly.

Peter anastasiouMansuo shannonEli lillyCompany lillyPrnewswire capsida biotherapeutics incPrevail therapeuticsInvestigational new drug enablingCapsida biotherapeutics

Capsida Biotherapeutics Announces Publication in Nature Neuroscience From Caltech Demonstrating Robust, Non-invasive IV Gene Delivery Targeted to the Brain While Avoiding Liver

/PRNewswire/ Capsida Biotherapeutics, Inc., an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies.

Nick goedenNicholas flytzanisViviana gradinaruPrnewswire capsida biotherapeutics incCalifornia institute of technology caltechChen institute for neuroscienceNature neuroscienceBiological engineeringCellular neuroscienceChen instituteCalifornia instituteChief technology officerChief science officerCapsida biotherapeuticsHealth care amp hospitalsOlls and research

vimarsana © 2020. All Rights Reserved.